Related Experiment Video
Updated: Jul 12, 2026
08:53
Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
Published on: February 18, 2011
Chromosomal mutagen sensitivity associated with mutations in BRCA genes
1Universitätsklinikum Ulm, Abteilung Humangenetik, Ulm, Germany. guenter.speit@medizin.uni-ulm.de
Cytogenetic and Genome Research
|May 27, 2004
Summary
Chromosomal mutagen sensitivity, a heritable trait, is linked to breast cancer risk, particularly in BRCA1/BRCA2 mutation carriers. Different tests reveal distinct sensitivities, suggesting varied DNA repair defects. Lymphoblastoid cell lines are less reliable for studying this sensitivity.
Area of Science:
- Genetics
- Cancer Biology
- Molecular Toxicology
Background:
- Chromosomal mutagen sensitivity is observed in various cancer patients, including a subset of breast cancer patients.
- Heritability studies suggest genetic factors, potentially involving DNA repair genes, contribute to mutagen sensitivity in breast cancer.
- BRCA1 and BRCA2 mutations, found in familial breast cancer, are associated with mutagen sensitivity, impacting genomic integrity.
Purpose of the Study:
- To investigate the heritability and genetic basis of chromosomal mutagen sensitivity in breast cancer patients.
- To evaluate the utility of different assays (G2 chromosome aberration test, G(0) micronucleus test) in detecting mutagen sensitivity.
- To explore the association between BRCA1/BRCA2 mutations and mutagen sensitivity, and its implications for cancer risk and therapy.
Main Methods:
- Utilized the G2 chromosome aberration test and the G(0) micronucleus test (MNT) to assess chromosomal mutagen sensitivity.
- Analyzed segregation in families of breast cancer patients to determine heritability.
- Examined mutagen sensitivity in lymphocytes and lymphoblastoid cell lines (LCLs) from breast cancer patients, including BRCA1/BRCA2 mutation carriers, following exposure to ionizing radiation and chemical mutagens.
Main Results:
- No clear correlation was found between G2 and G(0) test results, indicating distinct underlying genetic defects.
- BRCA1/BRCA2 mutation carriers showed mutagen sensitivity, with the MNT being more effective than the G2 assay in differentiating carriers from controls.
- Enhanced micronuclei formation was observed in lymphocytes but not consistently in LCLs from BRCA1 mutation carriers, suggesting LCLs have limited utility for studying mutagen sensitivity mechanisms.
Conclusions:
- Mutagen sensitivity in breast cancer patients likely involves heritable defects in DNA repair pathways.
- BRCA1/BRCA2 mutations are associated with increased mutagen sensitivity, potentially elevating cancer risk from radiation or certain therapies.
- Lymphocytes are more suitable than LCLs for studying the mechanisms of chromosomal mutagen sensitivity related to BRCA mutations.
More Related Videos
Related Concept Videos
01:36Mismatch Repair
Overview
01:39Mutations
Overview
01:35Mutations
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
01:20Mismatch Repair
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
01:25Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
01:30Spontaneous and Induced Mutations
Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).